INTANGIBLE ASSETS	12 Months Ended
Nov. 30, 2021
INTANGIBLE ASSETS
INTANGIBLE ASSETS	NOTE 5. INTANGIBLE ASSETS On December 22, 2017, Trident exercised its option under our Exclusive License Agreement (dated March 1, 2015) to purchase the Brain Armor® brand from DSM Nutrition Products LLC (“DSM”). Subsequently, the parties have executed applicable trademark assignment and purchase agreements necessary to transfer all global intellectual property rights in the Brain Armor brand to Trident. In lieu of a $400,000 cash payment to DSM for the value of the Brain Armor® brand as initially intended, the Company agreed to meet certain conditions, that when satisfied will have an equivalent value of $400,000. The costs incurred to meet these conditions are being charged to intangible assets. As of November 30, 2021 and 2020, the Company has recorded $400,000 of costs to the asset account. Of this amount $200,000 is paid over time as the Company purchases omega-3 oil from DSM pursuant to its exclusive supply agreement. During the 12 months ended November 30, 2021 and 2020, no payments were made to DSM in connection with this liability. The amount outstanding as of November 30,2021 is $79,040 The Company reviewed the intangible asset for impairment and booked an impairment charge of $400,000 for the full value of the asset on November 30, 2021.

INTANGIBLE ASSETS

12 Months Ended

Nov. 30, 2021

NOTE 5. INTANGIBLE ASSETS

On December 22, 2017, Trident exercised its option under our Exclusive License Agreement (dated March 1, 2015) to purchase the Brain Armor® brand from DSM Nutrition Products LLC (“DSM”). Subsequently, the parties have executed applicable trademark assignment and purchase agreements necessary to transfer all global intellectual property rights in the Brain Armor brand to Trident. In lieu of a $400,000 cash payment to DSM for the value of the Brain Armor® brand as initially intended, the Company agreed to meet certain conditions, that when satisfied will have an equivalent value of $400,000. The costs incurred to meet these conditions are being charged to intangible assets. As of November 30, 2021 and 2020, the Company has recorded $400,000 of costs to the asset account. Of this amount $200,000 is paid over time as the Company purchases omega-3 oil from DSM pursuant to its exclusive supply agreement. During the 12 months ended November 30, 2021 and 2020, no payments were made to DSM in connection with this liability. The amount outstanding as of November 30,2021 is $79,040

The Company reviewed the intangible asset for impairment and booked an impairment charge of $400,000 for the full value of the asset on November 30, 2021.